{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:27:09Z","timestamp":1791235629622,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["HLRC-9705"],"award-info":[{"award-number":["HLRC-9705"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>This study focused on the beneficial effects of <jats:italic>Capparis spinosa<\/jats:italic> (CS) treatment on the steatohepatitis induced by the administration of a high-fat emulsion in rats. Changes of hepatic expression and secretion of fibroblast growth factor 21 (FGF21) were also evaluated as a probable mechanism of the CS effects on fatty liver. Male Wistar rats were allocated in different groups to receive a normal diet (NC group), a high-fat diet (HF group), or the high-fat emulsion plus CS extract at a dose of 20\u00a0mg\/kg (HF+CS group). Body and liver weight, liver index, serum biochemical factors, histopathological examination, and serum level and hepatic gene expression of FGF21 were determined.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>CS administration markedly reduced liver weight and index, serum levels of glucose, lipids, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) and improved histological features of nonalcoholic steatohepatitis (NASH) which were induced by HF feeding in this model. CS supplementation also restored the decreased hepatic and serum FGF21 levels in the fatty liver rats. We propose that the FGF21 up-regulation may partly account for the favorable effects of CS in this steatohepatitis model.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13104-020-05200-4","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T12:02:53Z","timestamp":1595937773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Capparis spinosa improves the high fat diet-induced non-alcoholic steatohepatitis in rats: the possible role of FGF21"],"prefix":"10.1186","volume":"13","author":[{"given":"Rasoul","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Yaghooti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taha","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laya Sadat","family":"Khorsandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-8099","authenticated-orcid":false,"given":"Narges","family":"Mohammadtaghvaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"issue":"3","key":"5200_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","volume":"64","author":"J Liu","year":"2015","unstructured":"Liu J, Xu Y, Hu Y, Wang G. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism. 2015;64(3):380\u201390. https:\/\/doi.org\/10.1016\/j.metabol.2014.11.009.","journal-title":"Metabolism."},{"key":"5200_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cca.2019.08.005","volume":"498","author":"X Su","year":"2019","unstructured":"Su X, Kong Y, Peng D. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clin Chim Acta. 2019;498:30\u20137. https:\/\/doi.org\/10.1016\/j.cca.2019.08.005.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"5200_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12020-015-0845-x","volume":"53","author":"JY Jeon","year":"2016","unstructured":"Jeon JY, Choi S-E, Ha ES, Kim TH, Jung JG, Han SJ, et al. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles. Endocrine. 2016;53(1):97\u2013106. https:\/\/doi.org\/10.1007\/s12020-015-0845-x.","journal-title":"Endocrine"},{"key":"5200_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","volume":"418","author":"M Asrih","year":"2015","unstructured":"Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link? Mol Cell Endocrinol. 2015;418:55\u201365. https:\/\/doi.org\/10.1016\/j.mce.2015.02.018.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"5200_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.clnu.2016.09.020","volume":"36","author":"HL Amiri","year":"2017","unstructured":"Amiri HL, Agah S, Azar JT, Hosseini S, Shidfar F, Mousavi SN. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: randomized, controlled, double-blind trial. Clin Nutr. 2017;36(6):1490\u20137. https:\/\/doi.org\/10.1016\/j.clnu.2016.09.020.","journal-title":"Clin Nutr"},{"key":"5200_CR6","first-page":"9","volume":"19","author":"HL Amiri","year":"2016","unstructured":"Amiri HL, Agah S, Mousavi SN, Hosseini AF, Shidfar F. Regression of non-alcoholic fatty liver by vitamin D supplement: a double-blind randomized controlled clinical trial. Arch Iran Med. 2016;19:9.","journal-title":"Arch Iran Med."},{"issue":"2","key":"5200_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12011-017-1059-2","volume":"181","author":"SN Mousavi","year":"2018","unstructured":"Mousavi SN, Faghihi A, Motaghinejad M, Shiasi M, Imanparast F, Amiri HL, et al. Zinc and selenium co-supplementation reduces some lipid peroxidation and angiogenesis markers in a rat model of NAFLD-fed high fat diet. Biol Trace Elem Res. 2018;181(2):288\u201395. https:\/\/doi.org\/10.1007\/s12011-017-1059-2.","journal-title":"Biol Trace Elem Res"},{"issue":"12","key":"5200_CR8","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","volume":"12","author":"VS Chachay","year":"2014","unstructured":"Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O\u2019Moore-Sullivan TM, Lee P, et al. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12(12):2092\u2013103. https:\/\/doi.org\/10.1016\/j.cgh.2014.02.024.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"5200_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u201383. https:\/\/doi.org\/10.1001\/jama.2020.2298.","journal-title":"JAMA"},{"key":"5200_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/TCRM.S124621","volume":"13","author":"RA Khan","year":"2017","unstructured":"Khan RA, Kapur P, Jain A, Farah F, Bhandari U. Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients. Ther Clin Risk Manag. 2017;13:139. https:\/\/doi.org\/10.2147\/TCRM.S124621.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"5200_CR11","first-page":"797","volume":"44","author":"F Shidfar","year":"2015","unstructured":"Shidfar F, Jazayeri S, Mousavi SN, Malek M, Hosseini A, Khoshpey B. Does supplementation with royal jelly improve oxidative stress and insulin resistance in type 2 diabetic patients? Iran J Public Health. 2015;44(6):797.","journal-title":"Iran J Public Health."},{"key":"5200_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","volume":"130","author":"M Bagherniya","year":"2018","unstructured":"Bagherniya M, Nobili V, Blesso CN, Sahebkar A. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review. Pharmacol Res. 2018;130:213\u201340. https:\/\/doi.org\/10.1016\/j.phrs.2017.12.020.","journal-title":"Pharmacol Res"},{"issue":"5","key":"5200_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ctim.2013.07.003","volume":"21","author":"HF Huseini","year":"2013","unstructured":"Huseini HF, Hasani-Rnjbar S, Nayebi N, Heshmat R, Sigaroodi FK, Ahvazi M, et al. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2013;21(5):447\u201352. https:\/\/doi.org\/10.1016\/j.ctim.2013.07.003.","journal-title":"Complement Ther Med."},{"key":"5200_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jff.2017.05.001","volume":"35","author":"A Mollica","year":"2017","unstructured":"Mollica A, Zengin G, Locatelli M, Stefanucci A, Mocan A, Macedonio G, et al. Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: in vivo and in vitro evaluation of its nutraceutical potential. J Funct Foods. 2017;35:32\u201342. https:\/\/doi.org\/10.1016\/j.jff.2017.05.001.","journal-title":"J Funct Foods."},{"issue":"11","key":"5200_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/ptr.5684","volume":"30","author":"SF Nabavi","year":"2016","unstructured":"Nabavi SF, Maggi F, Daglia M, Habtemariam S, Rastrelli L, Nabavi SM. Pharmacological effects of Capparis spinosa L. Phytother Res. 2016;30(11):1733\u201344. https:\/\/doi.org\/10.1002\/ptr.5684.","journal-title":"Phytother Res."},{"issue":"1","key":"5200_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1871530318666180821131201","volume":"19","author":"H Vahid","year":"2019","unstructured":"Vahid H, Bonakdaran S, Khorasani ZM, Jarahi L, Rakhshandeh H, Ghorbani A, et al. Effect of Capparis spinosa Extract on metabolic parameters in patients with Type-2 diabetes: a randomized controlled trial. Endocr Metab Immune Disord Drug Targets. 2019;19(1):100\u20137. https:\/\/doi.org\/10.2174\/1871530318666180821131201.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"5200_CR17","first-page":"191","volume":"7","author":"M Eddouks","year":"2017","unstructured":"Eddouks M, Lemhadri A, Hebi M, Hidani AE, Zeggwagh NA, Bouhali BE, et al. Capparis spinosa L. aqueous extract evokes antidiabetic effect in streptozotocin-induced diabetic mice. Avicenna J Phytomedicine. 2017;7(2):191.","journal-title":"Avicenna J Phytomedicine."},{"issue":"24","key":"5200_CR18","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1021\/jf1034114","volume":"58","author":"H Zhou","year":"2010","unstructured":"Zhou H, Jian R, Kang J, Huang X, Li Y, Zhuang C, et al. Anti-inflammatory effects of caper (Capparis spinosa L.) fruit aqueous extract and the isolation of main phytochemicals. J Agric Food Chem. 2010;58(24):12717\u201321. https:\/\/doi.org\/10.1021\/jf1034114.","journal-title":"J Agric Food Chem"},{"key":"5200_CR19","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.biopha.2016.10.061","volume":"84","author":"MT Jalali","year":"2016","unstructured":"Jalali MT, Mohammadtaghvaei N, Larky DA. Investigating the effects of Capparis spinosa on hepatic gluconeogenesis and lipid content in streptozotocin-induced diabetic rats. Biomed Pharmacother. 2016;84:1243\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2016.10.061.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"5200_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.lfs.2006.03.021","volume":"79","author":"Y Zou","year":"2006","unstructured":"Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006;79(11):1100\u20137. https:\/\/doi.org\/10.1016\/j.lfs.2006.03.021.","journal-title":"Life Sci"},{"issue":"6","key":"5200_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology"},{"issue":"9","key":"5200_CR22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/S0002-9270(99)00433-5","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467\u201374. https:\/\/doi.org\/10.1016\/S0002-9270(99)00433-5.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"5200_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2337\/db15-1094","volume":"65","author":"A Ejaz","year":"2016","unstructured":"Ejaz A, Martinez-Guino L, Goldfine AB, Ribas-Aulinas F, De Nigris V, Rib\u00f3 S, et al. Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes. 2016;65(4):902\u201312. https:\/\/doi.org\/10.2337\/db15-1094.","journal-title":"Diabetes"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05200-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:33:54Z","timestamp":1627428834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05200-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5200"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05200-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was approved by the Ethics Committee of Research Center & Experimental Animal House, Ahvaz Jundishapur University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}